About 565 results

ALLMedicine™ Shigellosis Center

Research & Reviews  188 results

Shigellosis in young children in low-income and middle-income countries: insights from ...
Current Opinion in Infectious Diseases; Platts-Mills JA, Rogawski McQuade ET

Jul 16th, 2021 - To describe the impact of molecular diagnostics on our understanding of the burden and epidemiology of shigellosis in children in low-income and middle-income countries. The incorporation of molecular diagnostics has led to a substantial increase ...

Global projections of temperature-attributable mortality due to enteric infections: a m...
The Lancet. Planetary Health; Chua PLC, Huber V et. al.

Jul 11th, 2021 - Mortality due to enteric infections is projected to increase because of global warming; however, the different temperature sensitivities of major enteric pathogens have not yet been considered in projections on a global scale. We aimed to project ...

Circulation of multi-drug-resistant Shigella sonnei and Shigella flexneri among men who...
International Journal of Antimicrobial Agents; Moreno-Mingorance A, Espinal P et. al.

Jun 23rd, 2021 - In high-income countries, shigellosis is mainly found in travellers to high-risk regions or in men who have sex with men (MSM). This study investigated the genomic characteristics and the features of antimicrobial resistance of MSM-associated Shig...

Relative transmissibility of shigellosis among different age groups: A modeling study i...
PLoS Neglected Tropical Diseases; Zhao Z, Chen Q et. al.

Jun 11th, 2021 - Shigellosis is a heavy disease burden in China especially in children aged under 5 years. However, the age-related factors involved in transmission of shigellosis are unclear. An age-specific Susceptible-Exposed-Infectious/Asymptomatic-Recovered (...

2021 European Guideline on the management of proctitis, proctocolitis and enteritis cau...
Journal of the European Academy of Dermatology and Venere... de Vries HJC, Nori AV et. al.

Jun 1st, 2021 - This guideline intents to offer guidance on the diagnosis and management of patients with gastrointestinal symptoms and a suspected sexually transmitted cause. Proctitis is defined as an inflammatory syndrome of the anal canal and/or the rectum. I...

see more →

Drugs  28 results see all →

Clinicaltrials.gov  5 results

Shigella Sonnel O-SPC/rBRU Conjugate Vaccine

Dec 16th, 2019 - The active ingredient of this Shigella sonnei O-SP-core conjugate vaccine is a saccharide-protein conjugate composed of a fragment of S. sonnei LPS. The saccharide component consists of an average of 3.5 repeat units of the O-SP plus the core regi...

A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Sep 6th, 2018 - The purpose of this study is to evaluate the efficacy, safety and immunogenicity of the GSK3536852A vaccine, which was designed to protect against shigellosis caused by Shigella sonnei (S. sonnei) and is using the new Generalized Modules for Membr...

Shigella Sonnei OSPC-rDT Conjugate Vaccine

Jul 2nd, 2017 - The active ingredient of this Shigella sonnei O-SP-core conjugate vaccine is a saccharide-protein conjugate composed of a fragment of S. sonnei LPS. The saccharide component consists of an average of 3.5 repeat units of the O-SP plus the core regi...

The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study

Aug 6th, 2015 - Postinfectious-IBS (PI-IBS) can be defined as the acute onset of new IBS symptoms in an individual, who has not previously met the criteria for IBS, immediately following an acute illness characterized by 2 or more of the following: fever, vomitin...

Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections

The aim of this study is to accelerate the development of vaccine candidates against diarrheal diseases caused by Shigella and Enterotoxigenic Escherichia coli (ETEC). We plan to identify cases of laboratory-proven shigellosis and ETEC-associated ...

see more →

News  4 results

Fast Five Quiz: How Much Do You Know About Common Conditions Associated With Diarrhea?

Aug 7th, 2018 - General supportive care of patients with shigellosis includes: Infection with Shigella is normally self-limited. The average duration of gastrointestinal symptoms of untreated shigellosis is 7 days Antibiotic treatment is indicated in some patient...

VIDEO: Infectious enteritis quadrupled short-term risk of IBS
Internal Medicine News; Amy Karon

Feb 24th, 2017 - More than 10% of patients developed irritable bowel syndrome (IBS) within a year after infectious enteritis, which gave them a more than fourfold greater risk than that of controls, according to a systematic review and meta-analysis of 45 studies.

United States experiencing drug-resistant shigellosis outbreak
Deepak Chitnis

Apr 2nd, 2015 - The United States is currently experiencing an outbreak of shigellosis caused by a strain of the Shigella sonnei bacteria that is resistant to ciprofloxacin, the most commonly prescribed antimicrobial treatment for shigellosis. In its Morbidity an.

Multidrug-Resistant Shigellosis Outbreaks
Mary Anne Jackson

pdnews@elsevier. com As my community battles another large Shigella outbreak, I wanted to point out a few aspects of the infection that are often overlooked.

see more →

Patient Education  1 results see all →